MonTa Biosciences is attending the BioEurope conference in Hamburg to meet with biotech and pharma companies [...]
MonTa Biosciences is attending the cancer immunotherapy SITC conference in Washington DC to present data on our [...]
MonTa Biosciences attends the ESMO conference in Barcelona to meet with Key Opinion Leaders to [...]
MonTa Biosciences is invited to a fireside interview at the IP-FAIR conference in Copenhagen on May 8.
MonTa Biosciences join the pharma business conference BioEurope in Vienna to meet with pharma and biotech [...]
MonTa Biosciences closes investment with Consolidated Holdings to secure future development towards clinical trials. Link
MonTa Biosciences is invited to speak and join panel discussion with major Big Pharma companies Roche [...]
MonTa Biosciences attend Bio in Boston from June 4-7th to meet and discuss partnership, collaborations and investment opportunities. Send [...]
MonTa Biosciences attend the AngloNordic Life science conference in London on Mya 24th to meet investors and network [...]
MonTa Biosciences attend the Biotechandmoney conference in London on February 5-6.
MonTa Biosciences attends the BioEurope partnering conference in Berlin from November 4-8. Please book a meeting with [...]
MonTa Biosciences announces completion of license agreements with UC San Diego and Danish Technical University. The immune [...]
MonTa Biosciences attends the Nordic Life Science Days in Malmö to meet with investors and pharma partners.
MonTa Biosciences recruits PhD, Esper Boel former SVP in Novo Nordisk and strategic adviosor in immunotherapy to its Board [...]
MonTa Biosciences attends BioEurope Spring in Barcelona to have meetings with more than 10 of the top [...]
MonTa Biosciences closes an investment from Pre-Seed Innovation to reach key milestones for our cancer [...]
MonTa Biosciences join the NOME Mentoring programme in the North Carolina Research Triangle and are appointed top [...]
MonTa Biosciences awarded to be included in the NOME Nordic Mentoring Network for Entrepreneurship. MonTa Biosciences is priviledged to be part [...]
A news article was published by the Danish Biotech media; Medwatch on the newly granted [...]
MonTa Biosciences is part of the XVac “Grand Solutions” granted an Investment from “Innovationsfonden”. The XVac project [...]